炎症和IL-4调节帕金森病和克罗恩病相关的激酶LRRK2
Dina Dikovskaya1,2, Rebecca Pemberton3, Matthew Taylor3,4
1Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK. Dina.dikovskaya@plymouth.ac.uk.
EMBO reports
|May 20, 2025
概括
研究人员开发了新的工具来研究免疫细胞中的氨酸丰富的重复蛋白激酶2 (LRRK2). 炎症对细胞类型的LRRK2活性产生不同的影响,为帕金森症提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 氨酸丰富的重复蛋白激酶2 (LRRK2) 的突变与帕金森病 (PD) 和克罗恩病 (CD) 有关.
- 在炎症过程中LRRK2的调节还不清楚.
- 了解LRRK2在免疫细胞中的作用对于炎症性疾病至关重要.
研究的目的:
- 开发用于测量单个细胞中LRRK2活性和表达的新型试验.
- 为了研究LRRK2在炎症反应中的细胞特异调节.
- 探索与PD相关的LRRK2突变对免疫细胞反应的影响.
主要方法:
- 为LRRK2活动开发流细胞测量试验.
- 创建一个EGFP-Lrrk2 knock-in记者小鼠模型.
- 对小鼠和人类免疫细胞中LRRK2表达和活性的分析.
主要成果:
- 炎症 (抗CD3) 增加了B细胞和单细胞中的LRRK2表达和活性.
- 炎症刺激LRRK2活动,但在成熟的中性粒细胞中减少表达.
- LRRK2-R1441C突变增强了单细胞/巨细胞中炎症诱导的LRRK2激活.
- 互白素-4 (IL-4) 在B细胞上调节LRRK2,模仿体内炎症效应.
结论:
- 新的工具提供了对免疫细胞中LRRK2调节的见解.
- 在不同类型的免疫细胞中,LRRK2对炎症表现出不同的反应.
- 这些发现突出了LRRK2在免疫反应中的复杂作用,以及在克罗恩病等炎症状况中潜在的治疗向.
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
T Cell Types and Functions
730
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
730
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Inflammatory Bowel Disease II: Crohn's Disease
144
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
144
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K


